Author

Shuji Sumie

Observed names: S. Sumie, SHUJI SUMIE

Observed institutions: Kurume University, United States Department of Veterans Affairs, Peking University, Veterans Health Administration, Yale University, VA Connecticut Healthcare System, Kurume University Hospital, Peking University People's Hospital, Pediatrics and Genetics, Nishinihon Hospital, National Liver Institute, Menoufia University

OpenAlex ID: A5111495157

Microvascular Invasion in Patients with Hepatocellular Carcinoma and Its Predictable Clinicopathological Factors

2008 · Shuji Sumie, Ryoko Kuromatsu, et al. · Annals of Surgical Oncology · 387

Hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis

2002 · Eiji Ando, Masatoshi Tanaka, et al. · Cancer · 320

PDF

Clearance of HCV Improves Insulin Resistance, Beta-Cell Function, and Hepatic Expression of Insulin Receptor Substrate 1 and 2

2007 · Takumi Kawaguchi, Tatsuya Ide, et al. · The American Journal of Gastroenterology · 254

The Significance of Classifying Microvascular Invasion in Patients with Hepatocellular Carcinoma

2013 · Shuji Sumie, Osamu Nakashima, et al. · Annals of Surgical Oncology · 201

Clinical characteristics and prognostic factors for advanced hepatocellular carcinoma with extrahepatic metastasis

2014 · HAJIME AINO, SHUJI SUMIE, et al. · Molecular and Clinical Oncology · 76

PDF

High prevalence of anticardiolipin antibodies in hepatitis C virus infection: lack of effects on thrombocytopenia and thrombotic complications

2000 · Masaru Harada, Yuko Fujisawa, et al. · Journal of Gastroenterology · 63

Interventional Radiology for Advanced Hepatocellular Carcinoma: Comparison of Hepatic Artery Infusion Chemotherapy and Transcatheter Arterial Lipiodol Chemoembolization

2003 · Shuji Sumie, Fumihiko Yamashita, et al. · American Journal of Roentgenology · 60

Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

2012 · Takashi Niizeki, Shuji Sumie, et al. · Journal of Gastroenterology · 59

PDF

Altered expression of glucagon‐like peptide‐1 and dipeptidyl peptidase IV in patients with HCV‐related glucose intolerance

2007 · Minoru Itou, Takumi Kawaguchi, et al. · Journal of Gastroenterology and Hepatology · 50

Diffusion-weighted magnetic resonance imaging predicts malignant potential in small hepatocellular carcinoma

2016 · Shusuke Okamura, Shuji Sumie, et al. · Digestive and Liver Disease · 49

Surveillance Program for Early Detection of Hepatocellular Carcinoma in Japan

2006 · Eiji Ando, Ryoko Kuromatsu, et al. · Journal of Clinical Gastroenterology · 49

Intra‐arterial therapy with cisplatin suspension in lipiodol and 5‐fluorouracil for hepatocellular carcinoma with portal vein tumour thrombosis

2010 · H. Nagamatsu, M. Hiraki, et al. · Alimentary Pharmacology & Therapeutics · 40

PDF

Branched‐chain amino acids improve insulin resistance in patients with hepatitis C virus‐related liver disease: report of two cases

2007 · Takumi Kawaguchi, Eitaro Taniguchi, et al. · Liver International · 40

Ischaemic colitis during interferon treatment for chronic hepatitis C: report of two cases and literature review

2011 · T. Kawaguchi, T. Ide, et al. · Journal of Viral Hepatitis · 36

Serum albumin level is a notable profiling factor for non‐ B , non‐ C hepatitis virus‐related hepatocellular carcinoma: A data‐mining analysis

2013 · Shingo Yamada, Atsushi Kawaguchi, et al. · Hepatology Research · 35

The systemic inflammatory response as a prognostic factor for advanced hepatocellular carcinoma with extrahepatic metastasis

2016 · HAJIME AINO, SHUJI SUMIE, et al. · Molecular and Clinical Oncology · 34

PDF

Efficacy, Safety, and Survival Factors for Sorafenib Treatment in Japanese Patients with Advanced Hepatocellular Carcinoma

2012 · Masahito Nakano, Masatoshi Tanaka, et al. · Oncology · 34

Total and High Molecular Weight Adiponectin and Hepatocellular Carcinoma with HCV Infection

2011 · Shuji Sumie, Takumi Kawaguchi, et al. · PLoS ONE · 33

PDF

Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan

2002 · Yoichi Yano, Fumihiko Yamashita, et al. · The American Journal of Gastroenterology · 31

Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection

2007 · Shuji Sumie, Takumi Kawaguchi, et al. · Oncology Reports · 29

PDF

Hepatic arterial infusion chemoembolization therapy for advanced hepatocellular carcinoma: multicenter phase II study

2016 · Hiroaki Nagamatsu, Shuji Sumie, et al. · Cancer Chemotherapy and Pharmacology · 28

CD 34+ cell therapy is safe and effective in slowing the decline of hepatic reserve function in patients with decompensated liver cirrhosis

2014 · Toru Nakamura, Takuji Torimura, et al. · Journal of Gastroenterology and Hepatology · 25

Pigment Epithelium-Derived Factor Inhibits Lysosomal Degradation of Bcl-xL and Apoptosis in HepG2 cells

2009 · Takumi Kawaguchi, Sho-ichi Yamagishi, et al. · American Journal Of Pathology · 22

PDF

Effect of pioglitazone on outcome following curative treatment for hepatocellular carcinoma in patients with hepatitis C virus infection: A prospective study

2014 · SHUJI SUMIE, TAKUMI KAWAGUCHI, et al. · Molecular and Clinical Oncology · 16

PDF

Adipocytokine involvement in hepatocellular carcinoma after sustained response to interferon for chronic hepatitis C

2010 · Nobuyoshi Fukushima, Ryoko Kuromatsu, et al. · Hepatology Research · 16

Works count: 50

Citation count: 2,101

H-index: 22

I10-index: 30